SEC 13F Intelligence

Sanofi / NVV1

Sanofi’s Novavax Inc Position

Does Sanofi own Novavax Inc (NVV1)? Yes — 6.88M shares worth $56M (+16.67% of its 13F portfolio) as of Q1 2026.

Position Value
$56M
Q1 2026
Shares
6.88M
% of Portfolio
+16.67%
Quarters Held
6
currently held

Position History NVV1

Reported value by quarter
Q4 ’24: $55MQ4 ’24Q1 ’25: $44MQ1 ’25Q2 ’25: $43MQ2 ’25Q3 ’25: $60MQ3 ’25Q4 ’25: $46MQ4 ’25Q1 ’26: $56MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20266.88M$56M+16.67%
Q4 20256.88M$46M+14.90%
Q3 20256.88M$60M+22.91%
Q2 20256.88M$43M+24.67%
Q1 20256.88M$44M+26.58%
Q4 20246.88M$55M+31.73%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sanofi’s full portfolio or all institutional holders of NVV1.